Coordinated Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$437K Buy
15,553
+336
+2% +$8.95K 0.25% 113
2025
Q4
$379K Buy
15,217
+3,417
+29% +$86.2K 0.22% 122
2025
Q3
$301K Buy
11,800
+2,650
+29% +$65.4K 0.19% 130
2025
Q2
$222K Buy
9,150
+400
+5% +$9.33K 0.15% 138
2025
Q1
$222K Buy
8,750
+959
+12% +$25.1K 0.17% 129
2024
Q4
$207K Buy
+7,791
New +$211K 0.16% 134

Other funds holding PFE

Coordinated Financial Services's PFE Position: Q1 2026 in Review

Coordinated Financial Services increased its Pfizer (PFE) stake by 2.2% in Q1 2026, buying an estimated $8.95K and bringing the position to 15,553 shares worth $437K. The position accounts for 0.25% of the portfolio, ranked #113.

Coordinated Financial Services first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Coordinated Financial Services held 15,553 shares of Pfizer worth $437K as of Q1 2026.
  • Coordinated Financial Services bought 336 Pfizer shares in Q1 2026, an estimated $8.95K.
  • Pfizer made up 0.25% of Coordinated Financial Services's portfolio in Q1 2026, its #113 holding.
  • Coordinated Financial Services first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Coordinated Financial Services's 13F filing for Q1 2026, filed 4 May 2026.